Ethical considerations for the inclusion of patient reported outcomes in clinical research

17 May 2022 - An international consensus Delphi process was developed according to the Enhancing the Quality and Transparency of Health ...

Read more →

ICER publishes 2022 research protocol for assessing unsupported price increases on prescription drugs

14 April 2022 - Final assessment to be published on 6 December 2022. ...

Read more →

EMA launches the Regulatory Science Research Needs initiative

15 December 2021 - For the first time, EMA has issued a list of regulatory science topics that need further research ...

Read more →

Competing with, and learning from, China in the global pharmaceutical innovation race

15 November 2021 - President Joe Biden has promoted investment in technology based industries, including the life sciences, as a strategic ...

Read more →

How much does it cost to research and develop a new drug? A systematic review and assessment

15 October 2021 - Debate over the viability of the current commercial research and development model is on-going.  ...

Read more →

EMA implements new measures to minimise animal testing during medicines development

29 September 2021 - EMA is putting in place special support to developers to replace, reduce and refine animal use for ...

Read more →

Canada should negotiate a fairer share of drug R&D costs

23 September 2021 - Instead of relying on price regulation, Canada should engage in negotiations about drug pricing. ...

Read more →

House report: drug companies spent more on buybacks, dividends than research

8 July 2021 - House Democrats on Thursday released a report that found that the 14 leading drug companies paid ...

Read more →

Cancer researcher David Thomas says more should be done attract big pharma

18 April 2021 - A Garvan Institute cancer researcher says the government needs to attract big pharmaceutical companies to Australia ...

Read more →

MHRA pilot seeks evidence of patient involvement in R&D

25 March 2021 - The UK MHRA has begun a pilot project to encourage patient involvement in drug development, asking ...

Read more →

Taxpayers fund research and drug companies make a fortune

24 March 2021 - The pharmaceutical industry doesn’t want things to change, but Americans can have both lower prices and innovation. ...

Read more →

Remdesivir’s hefty price tag ignores NIH investment in its creation

22 October 2020 - Throughout the Democratic presidential primary, candidates cast a spotlight on the broken U.S. health care system ...

Read more →

Financing drug innovation in the US: current framework and emerging challenges

19 August 2020 - The current US drug innovation financing framework rests on the notion that a defined period of marketing ...

Read more →

Coming of age: emerging health preference research based on established scientific standards

10 August 2020 - Value in Health themed section enhances the scientific respectability and relevance of health preference research. ...

Read more →

Australian start-ups push for bigger role in vaccine making

9 August 2020 - An Australian startup racing to develop a successful coronavirus vaccine has urged the federal government to ...

Read more →